Potent pseudopeptide bombesin-like agonists and antagonists. Correlation of ordered conformation of bombesin analogs to receptor activity.

Bombesin-like pseudopeptides have been synthesized, and certain physicochemical properties and biological activities have been examined. Bombesin and the related peptide litorin were modified at positions 13-14 and 8-9, respectively, with psi[CH2S] and psi[CH2N(CH3)]. [Phe13 psi[CH2S]Leu14]bombesin and [Phe8 psi[CH2S]-Leu9]litorin bound to the murine pancreatic bombesin/gastrin releasing peptide receptor with similar dissociation constants (Kd = 3.9 and 3.4 nM, respectively). Increased potency was achieved by oxidation of the thiomethylene ether to two diastereomeric sulfoxides (isomer I, Kd = 1.6 nM and isomer II, Kd = 0.89 nM. Further oxidation to the sulfone decreased potency ([Phe8 psi[CH2SO2]Leu9]litorin, Kd = 9.9 nM). All five analogs were receptor antagonists as determined by phosphatidylinositol turnover in murine pancreas. In contrast to these peptide backbone substitutions, a psi[CH2N(CH3)] at the 8-9 amide bond position resulted in an agonist. The analogs were compared with those of litorin (Kd = 0.1 nM) and [Leu9]litorin (Kd = 0.17 nM) by CD and fluorescence spectroscopy. The CD spectra demonstrated ordered conformation for all the peptides in TFE. Different conformations corresponding to agonist and antagonist peptides were suggested by CD. Based on the pH-dependence of the fluorescence spectra of the peptides in a zwitterionic detergent, two titratable groups were identified (pKa = 6.3 and 8.5). The lower pKa is found in the agonist analogs but not in the psi [CH2S]-containing antagonist.

[1]  J. A. Malikayil,et al.  Micelle-bound conformations of a bombesin/gastrin releasing peptide receptor agonist and an antagonist by two-dimensional NMR and restrained molecular dynamics. , 1992, Biochemistry.

[2]  E. Sausville,et al.  Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. , 1991, The Journal of biological chemistry.

[3]  R. Jensen,et al.  Covalently cyclized agonist and antagonist analogues of bombesin and related peptides. , 1991, The Journal of biological chemistry.

[4]  D. Heimbrook,et al.  Gastrin releasing peptide antagonists with improved potency and stability. , 1991, Journal of medicinal chemistry.

[5]  A. Cardin,et al.  Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin , 1991, Regulatory Peptides.

[6]  R. Jensen,et al.  Progress in the development of potent bombesin receptor antagonists. , 1991, Trends in pharmacological sciences.

[7]  J R Brown,et al.  Potent and highly selective neurokinin antagonists. , 1990, Journal of medicinal chemistry.

[8]  J. Jurayj,et al.  SYNTHESIS, BIOLOGICAL TESTING, AND STEREOCHEMICAL ASSIGNMENT OF AN END GROUP MODIFIED RETRO-INVERSO BOMBESIN C-TERMINAL NONAPEPTIDE , 1990 .

[9]  J. Collins,et al.  NMR identification of a partial helical conformation for bombesin in solution. , 1990, European journal of biochemistry.

[10]  R. Jensen,et al.  Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. , 1990, Biochemistry.

[11]  S. Harbeson,et al.  Synthesis and biological activity of [Ψ(CH2NH)] analogs of neurokinin A4–10 , 1990 .

[12]  D. Heimbrook,et al.  A gastrin-releasing peptide antagonist containing A psi (CH2O) amide bond surrogate. , 1989, Biochemical and biophysical research communications.

[13]  R. Jensen,et al.  Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity. , 1989, The Journal of biological chemistry.

[14]  D. Heimbrook,et al.  Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonists. , 1989, The Journal of biological chemistry.

[15]  R. Jensen,et al.  Effect of substitutions in position 12 of bombesin on antagonist activity , 1989, Peptides.

[16]  R. Bruzzone Mechanism of action of bombesin on amylase secretion. Evidence for a Ca2+-independent pathway. , 1989, European journal of biochemistry.

[17]  C. F. Hayward,et al.  N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue. , 1989, Life sciences.

[18]  V. Erspamer Discovery, Isolation, and Characterization of Bombesin‐like Peptides , 1988 .

[19]  C. Severini,et al.  Parallel bioassay of 27 bombesin-like peptides on 9 smooth muscle preparations. Structure-activity relationships and bombesin receptor subtypes , 1988, Regulatory Peptides.

[20]  R. Jensen,et al.  Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. , 1988, The Journal of biological chemistry.

[21]  R. Schwyzer,et al.  Membrane structure of bombesin studied by infrared spectroscopy. Prediction of membrane interactions of gastrin-releasing peptide, neuromedin B, and neuromedin C. , 1987, Biochemistry.

[22]  D. Coy,et al.  Solid phase synthesis of peptides containing the CH2NH peptide bond isostere , 1987, Peptides.

[23]  L. Masotti,et al.  Conformational flexibility of the hormonal peptide bombesin and its interaction with lipids. , 1986, Biochemical and biophysical research communications.

[24]  J. V. Edwards,et al.  In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs. , 1986, Biochemical and biophysical research communications.

[25]  L. Gierasch,et al.  Compatibility of .beta.- and .gamma.-turn features with a peptide backbone modification: synthesis and conformational analysis of a model cyclic pseudopentapeptide , 1986 .

[26]  E. Peggion,et al.  Conformational properties of gastrin peptides: synthesis, biological activity, and preliminary CD characterization of the (Asp)5 analog of des-Trp1, Leu12-Minigastrin. , 1986, Biopolymers.

[27]  J. Morley The design of antagonists of regulatory peptides, and comments on their specificity. , 1986, Progress in brain research.

[28]  J. Bali,et al.  Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone. , 1985, Journal of medicinal chemistry.

[29]  John D. Minna,et al.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.

[30]  J. Fehrentz,et al.  An efficient synthesis of optically active α-(t-butoxycarbonylamino)-aldehydes from α-amino acids , 1983 .

[31]  V. Hruby,et al.  STRUCTURAL, CONFORMATIONAL AND DYNAMIC CONSIDERATIONS IN THE DEVELOPMENT OF PEPTIDE HORMONE ANTAGONISTS , 1982 .

[32]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[33]  J. Brahms,et al.  Determination of protein secondary structure in solution by vacuum ultraviolet circular dichroism. , 1980, Journal of molecular biology.

[34]  J. Rivier,et al.  Bombesin, bombesin analogues, and related peptides: effects on thermoregulation. , 1978, Biochemistry.

[35]  E. Kaiser,et al.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.

[36]  F. P. Underhill STUDIES ON THE METABOLISM OF AMMONIUM SALTS II. A NOTE ON THE ELIMINATION OF INGESTED AMMONIUM SALTS DURING A PERIOD OF PROLONGED INANITION , 1913 .